HemaSphere (May 2023)

P50 OVERALL SURVIVAL ADVANTAGE OF MONOCLONAL ANTIBODIES BASED-TREATMENTS IN MULTIPLE MYELOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

  • C. Nozzoli,
  • M. Pucillo,
  • M. Martino,
  • L. Giaccone,
  • A. Rambaldi,
  • E. Benedetti,
  • D. Russo,
  • N. Mordini,
  • P. Bernasconi,
  • S. Mangiacavalli,
  • P. Pioltelli,
  • P. Carluccio,
  • P. Galieni,
  • M. Ladetto,
  • S. Sica,
  • M. Isola,
  • M. De Martino,
  • E. Oldani,
  • E. Degrandi,
  • A. Biasco,
  • R. Fanin,
  • R. Saccardi,
  • F. Ciceri,
  • F. Patriarca,
  • on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

DOI
https://doi.org/10.1097/01.HS9.0000936328.14674.49
Journal volume & issue
Vol. 7, no. S2
pp. 38 – 38

Abstract

Read online

No abstracts available.